The cancellation of the ATM offering removes a significant dilutive overhang that had been in place for nearly a year. With zero shares sold, existing shareholders face no dilution from this facility. Monitor for the formal termination filing and any subsequent capital needs disclosure.
Price Chart
Executive Summary
EUDA Health Holdings filed a 424B5 prospectus supplement to suspend its $10.0 million at-the-market (ATM) offering and reduce the maximum aggregate offering price to zero. No shares were ever sold under the ATM Agreement, and the company has initiated termination of the agreement, effective 30 business days from June 5, 2026. This removes a potential dilutive overhang that had been in place since June 2025.
Key Facts
- EUDA suspends its $10.0 million ATM offering and reduces the maximum aggregate offering price to zero.
- No ordinary shares were ever sold under the ATM Agreement or the Filed Prospectus Supplements.
- Termination notice sent to Chardan Capital Markets on June 5, 2026; effective 30 business days later.
- Closing price on June 11, 2026 was $15.50 per share.
- Market cap is approximately $46 million.
Financial Impact
Removes potential dilution of up to $10.0 million (approximately 22% of current market cap) that was never utilized.
Risk Factors
- Company may still need capital and could pursue alternative financing that could be more dilutive or carry worse terms.
- The suspension is not yet final; termination effective date is 30 business days from June 5, 2026.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-028219 |
| Document: 0001493152-26-028219-index-headers.html | 0001493152-26-028219 |
| Document: 0001493152-26-028219-index.html | 0001493152-26-028219 |
| Document: 0001493152-26-028219.txt | 0001493152-26-028219 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $17.01 $14.90 | ▲ +12.40% | ▲ +11.25% | $14.46 (+14.99%) |
Oct 13, 2026 14d ago | 6-K | $17.01 $14.90 | ▼ −12.40% | ▼ −11.25% | $14.46 (−14.99%) |
Aug 26, 2026 8w ago | Press Release | $14.10 $13.84 | ▼ −1.84% | ▼ −1.72% | $14.46 (+2.55%) |
Aug 11, 2026 11w ago | EFFECT | $15.23 $14.49 | ▲ +4.87% | ▲ +4.47% | $14.46 (+5.06%) |
Jul 31, 2026 12w ago | 6-K | $19.30 $15.90 | ▼ −17.62% | ▼ −21.13% | $14.46 (−25.08%) |
Jul 22, 2026 13w ago | 424B5 | $14.00 $20.35 | ▲ +45.36% | ▲ +47.76% | $14.46 (+3.29%) |
Jun 11, 2026 19w ago | 424B5 | $15.02 $16.49 | ▲ +9.79% | ▲ +9.35% | $14.46 (−3.73%) |
Apr 28, 2026 26w ago | Press Release | $12.00 $16.31 | ▲ +35.92% | ▲ +34.22% | $14.46 (+20.50%) |
Mar 19, 2026 31w ago | Press Release | $7.98 $11.44 | ▲ +43.36% | ▲ +45.57% | $14.46 (+81.20%) |
Mar 4, 2026 33w ago | Press Release | $15.74 $10.04 | ▼ −36.21% | ▼ −34.88% | $14.46 (−8.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers